Skip to content

Cognitive impairment and brain imaging in patients who suffered myocardial infarction related cardiogenic shock: A pilot study.

Cognitive impairment and brain imaging in patients who suffered myocardial infarction related cardiogenic shock: A pilot study. - CRISIS Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57774
Enrollment
90
Registered
2024-12-13
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction Related Cardiogenic Shock (AMICS) Acute pumpfailure

Interventions

MRI of the brainMontreal Cognitive AssessmentAmsterdam IADL questionnaireInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE)&nbsp
EuroQol-5D, including EuroQol Visual Analog ScaleGeriatric Depression Scale&nbsp
Starkstein Apathy Scale&nbsp
Hospital anxiety and Depression Scale (HADS)&nbsp

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Hospitalised for AMICS approximately 2 (1-3) years ago • Age 18-75 years • Able to give informed consent • Knowledge of Dutch language • 30/60 patients must have been treated with Impella, VA-ECMO or both. AMI (no CS) Control cohort (n=30) • Hospitalised for AMI without CS approximately 2 (1-3) years • Age 18-75 years • Able to give informed consent • Knowledge of Dutch language

Exclusion criteria

Exclusion criteria: • MRI incompatibility

Design outcomes

Primary

MeasureTime frame
Cognitive impairment Total and gray matter volume and number and volume of white matter hyperintensities measured on MRI

Secondary

MeasureTime frame
• Total cerebrospinal fluid (CSF) volume (mL) • White matter tract damage • Cerebral blood flow (CBF) (gray matter, hippocampus) (mL/100g/min) • Locus Coeruleus contrast ratio

Countries

Netherlands

Contacts

Public ContactJ.P.S. Henriques

Amsterdam UMC

j.p.henriques@amsterdamumc.nl0205664503

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026